Upshaw–Schülman syndrome
Upshaw–Schülman syndrome is a rare, inherited autosomal recessive disorder characterized by a deficiency of the serine protease inhibitor, antithrombin. This syndrome is the only known genetic cause of chronic, relapsing thrombotic thrombocytopenic purpura (TTP), a blood disorder that causes blood clots to form in small blood vessels throughout the body.
Etiology[edit | edit source]
Upshaw–Schülman syndrome is caused by mutations in the SERPINC1 gene, which provides instructions for making antithrombin. Antithrombin is a protein that helps control blood clotting by blocking the activity of certain proteins that promote clotting. Mutations in the SERPINC1 gene reduce the amount of functional antithrombin in the blood, leading to an increased risk of abnormal blood clotting.
Clinical Presentation[edit | edit source]
The symptoms of Upshaw–Schülman syndrome typically begin in infancy or early childhood. They can include purpura, thrombocytopenia, hemolytic anemia, and neurological abnormalities such as stroke and seizures. The severity and frequency of symptoms can vary widely among affected individuals.
Diagnosis[edit | edit source]
Diagnosis of Upshaw–Schülman syndrome is based on clinical symptoms, family history, and laboratory tests that measure the level of antithrombin in the blood. Genetic testing can confirm the diagnosis by identifying mutations in the SERPINC1 gene.
Treatment[edit | edit source]
Treatment for Upshaw–Schülman syndrome is aimed at preventing and managing symptoms. This can include plasma exchange therapy to remove antibodies that contribute to TTP, and anticoagulant therapy to prevent blood clots. In severe cases, liver transplantation may be considered, as the liver is the primary site of antithrombin production.
Prognosis[edit | edit source]
With appropriate treatment, individuals with Upshaw–Schülman syndrome can lead relatively normal lives. However, they must be monitored closely for signs of TTP and other complications.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Upshaw–Schülman syndrome is a rare disease.
| Upshaw–Schülman syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
